Mapping HIV-linked infections unearths diagnosis 'blank spots' in Africa
A map of deadly infectious diseases known to attack the central nervous system (CNS) of people who are already suffering with ...
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...
A cure for HIV: 'One of the hardest goals in science'
Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...